Professional Experience
Dr. Borgquist combines clinical service, research leadership and academic responsibilities. Her roles involve patient care, leading research groups and mentoring clinicians and scientists.
- Current position and hospital:
- Clinical Professor and Chair in Clinical Oncology, Aarhus University.
- Senior Consultant, Department of Oncology, Aarhus University Hospital.
- Previous roles:
- Senior consultant and clinical trial unit roles at Skåne University Hospital, Lund.
- Academic appointments at Lund University and visiting research positions abroad.
- Mentorship and leadership: Supervisor of PhD students, head of translational research groups and leader in clinical-research integration within oncology units.
Academic Contributions
Dr. Borgquist is active in teaching, research supervision and dissemination of new knowledge. She links laboratory findings with clinical practice and takes part in international educational activities.
- Teaching positions: Clinical Professor at Aarhus University; guest lectures and course contributions at university level.
- Lectures and training courses: Invited lectures at national and international oncology meetings and university courses on breast cancer biology and prevention.
- Research interests: Breast cancer prevention, risk stratification, obesity and lipid biology in cancer, and translational pathology.
- Mentorship: Supervises doctoral candidates and leads course development that integrates molecular pathology with clinical decision making.
Areas of Expertise
Her clinical expertise is focused on breast cancer and the metabolic and molecular factors that affect risk and treatment outcomes. She applies research insights to personalise care.
- Conditions treated:
- Breast cancer (early-stage and metastatic).
- Endocrine-sensitive tumours and metabolic-influenced malignancies.
- Clinical strengths:
- Risk assessment and prevention strategies explained in patient-friendly terms.
- Translational approaches that combine biomarkers with treatment planning.
- Guidance for clinical trial participation and eligibility.
Publications and Research
Dr. Borgquist has an extensive peer-reviewed record that supports her authority in breast cancer research, including studies on statins, lipids and cancer risk. Her work informs both prevention strategies and treatment approaches.
- Selected peer-reviewed articles:
- Borgquist S. et al. — studies on statin use and breast cancer outcomes; investigation of statin effects on tumour biology and patient prognosis.
- Research on apolipoproteins, lipid profiles and cancer risk linking metabolic markers to oncologic outcomes.
- Translational reports and trial protocols examining lifestyle interventions and endocrine therapies in breast cancer patients.
- Research profiles: Institutional and researcher identifiers list her full publication record and ongoing projects for clinicians and patients seeking details.
Patient Care Philosophy
Dr. Borgquist emphasises evidence-based, compassionate and patient-centred care. She believes in educating patients and collaborating across disciplines to tailor treatments to individual needs.
- Communication: Prioritises clear explanations of diagnosis, treatment options and expected outcomes.
- Empathy and cultural sensitivity: Adapts communication to diverse patient backgrounds and needs.
- Patient education: Encourages lifestyle changes and prevention where evidence supports benefit.
- Approach to international patients: Experienced with international collaborations and clinical-trial frameworks; international referrals are handled through hospital procedures and international patient services.
Professional Affiliations
Memberships and leadership roles in research networks and professional organisations reinforce her clinical and academic standing. She participates in grant review and peer review for leading journals.
- Institutional roles: Chair/Clinical Professor at Aarhus University; Senior Consultant at Aarhus University Hospital.
- National and regional roles: Leadership in translational breast cancer groups and membership of research councils.
- International engagement: Reviewer for oncology journals and invited contributor to international consortia and conferences.
- Certifications: Specialist certification in Oncology (Sweden, 2012) and clinical licensure consistent with practice in Denmark and Sweden.
FAQs
- Is Signe Borgquist board-certified?
- Yes. Dr. Borgquist is a certified specialist in Oncology (Sweden, 2012) and holds senior consultant status at Aarhus University Hospital.
- What types of treatments does she provide?
- Dr. Borgquist provides systemic cancer therapies such as chemotherapy, endocrine therapy and targeted agents. She focuses on personalised treatment planning and clinical trial options. Surgical procedures are performed by surgical oncology teams when required.
- Does she treat international patients?
- Her work is internationally oriented through research collaborations. International patients may access care through Aarhus University Hospital’s international patient pathways, subject to hospital policies and referral requirements.
- How long is the typical hospital stay?
- Length of stay varies by treatment type and individual clinical needs. Many systemic treatments are given on an outpatient basis. Inpatient care is arranged if clinically necessary.
- What languages does she speak?
- Dr. Borgquist works in Denmark and Sweden and is experienced in English, enabling communication with international colleagues and patients.
- How can I be referred to see Dr. Borgquist?
- Referrals are normally required from a general practitioner or a specialist. International referrals should be coordinated with the hospital’s international patient office or the Department of Oncology administration.
- What practical benefits do patients gain from her research?
- Her research on lipids, obesity and statins supports risk-stratified prevention and may identify complementary interventions to improve treatment outcomes and reduce recurrence risk.
